TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript
All right. Good afternoon. I'm Eric Joseph, senior biotech analyst at JPMorgan. Our next presenting company is TG Therapeutics. And to present on behalf of the company is CEO, Mike Weiss. (Event Instructions)
Okay. With that, Mike?
Thanks, Eric, and thanks, everyone, for joining us. We have the honor to close out day two of the biotech JPM, I think, or at least Eric's team.
All right, so I'm going to get started here. First, I got to say big shout out to Blue, Michigan Wolverines, National Champions. I promise everyone that I put this on. So my daughters will be very pleased about this.
All right, so let's get going here. So I will be making some forward-looking statements. I usually say I may be making forward-looking statements. I will be making some forward-looking statements. For those of you who aren't, I do encourage you to review our public disclosure documents.
Okay, just a quick background before we get into some details.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |